Skip to Content

059 (Primaquine phosphate 26.3 mg (15 mg base))

Pill imprint 059 has been identified as Primaquine phosphate 26.3 mg (15 mg base).

Primaquine is used in the treatment of malaria prevention; pneumocystis pneumonia; malaria and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 26.3 mg (15 mg base) is not a controlled substance under the Controlled Substance Act (CSA).

Primaquine phosphate
Imprint:
059
Strength:
26.3 mg (15 mg base)
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimalarial quinolines
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Manufacturer:
Ingenus Pharmaceuticals NJ, LLC

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide